Skip to content
Back to Blog
Integrative Medicine

Why We Don't Recommend Stem Cell Therapy (Yet)

June 27, 20269 min read

The short answer

Are you anti-stem-cell?

No — we're anti-stem-cell-as-shortcut. The therapy has real applications in orthopedic repair, certain autoimmune conditions, and select neurodegenerative pictures. The marketing has run far ahead of the evidence, the source-and-quality question is largely unregulated, and most patients pursuing it would benefit more from sequencing the upstream work first.

Your Integrative Life Compass · Free

By 3pm on a normal day, you feel…

10 questions · 4 minutes · report emailed to you

This post is in active drafting. Slug live so cluster cross-links resolve. Full body shipping in the follow-up batch.

Outline

  1. What stem cell therapy actually is (autologous vs allogenic vs MSC vs exosomes — these are not the same thing).
  2. The patient archetypes where it's genuinely useful.
  3. The regulatory mess — US vs Panama/Mexico/Cayman/EU.
  4. Source quality — the part the marketing doesn't talk about.
  5. Why terrain matters more than the cells — what we sequence first.
  6. The economics — and the patient profile that pays for the wrong reason.
  7. When we'd recommend it (rare, specific, sequenced) and when we won't (most cases).
<!-- CHART: Stem cell modality types — what each is, what each is for, what the evidence base looks like -->

Full body next batch.

stem cell therapy
regenerative medicine
integrative medicine
longevity
cluster:klinghardt-practitioner-2026

High-intent questions

Frequently asked

Where to take this next

Four ways to go deeper

Your Next Step

Explore Our Foundation Program

Begin your integrative medicine journey with comprehensive assessments and personalized health plans.

Enjoying this article?

Get weekly health insights that cut through the noise. Join 9,000+ readers.

Your Integrative Life Compass · Free

You were never the problem. The protocol was.

Find Your Root Cause